Clinical Trial on the Therapy of the Reperfusion Injury during an Acute Myocardial Infarction

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN80646081

Enrollment

100

Registered

2005-09-01

Start date

2001-07-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocardial infarction Circulatory System Myocardial infarction

Interventions

Randomised controlled trial: A. Glutathione (GSH)/Cariporide B. Placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Age: 18-80, 1-6 hours after onset of chest pain, clinic and electrocardiogram (ECG) of an acute myocardial infarction, written informed consent

Exclusion criteria

Exclusion criteria: 1. Myocardial infarction within 28 days 2. Lysis therapy within 24 hours 3. Cardiogenic shock

Design outcomes

Primary

Measure	Time frame
Regional myocardial function 6 months after revascularisation	—

Secondary

Measure	Time frame
Infarct size, left ventricular ejection fraction	—

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026